The ARCAN Database is Used for Retrospective Non-interventional Research Projects. The Database Collects Clinical and Laboratory Data From Patients With Lymphoid Malignancies. The Database Doesn't Require Biological Sample of Patients, it Records Only Information Based on the Patients' Medical File.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03868527

Acronym

Arcan database

Enrollment

13000

Registered

2019-03-11

Start date

2003-01-31

Completion date

2025-12-31

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematologic Diseases

Brief summary

To identify the diagnostic and therapeutic approach (efficacy and toxicity) of patients with lymphoid malignant hemopathy who are managed in the hematology department.

Interventions

OTHERData collection

Data collection for biostatistical analysis about hematological diseases

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

16 Years to No maximum

Healthy volunteers

Inclusion criteria

\- Patients followed for hematological diseases in Lyon Sud Hospital

Exclusion criteria

\- Patients who doesn't have hematological diseases

Design outcomes

Primary

Measure	Time frame	Description
Progression-free survival	730 days	Period between the end of the first treatment and the first confirmed relapse of lymphoma of patients who have received treatment to treat their lymphoma.

Countries

France

Contacts

Primary ContactGilles Salles, MD

gilles.salles@chu-lyon.fr0478864307

Backup ContactMarion Choquet

marion.choquet@chu-lyon.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026